Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Nov 24:9:803923.
doi: 10.3389/fped.2021.803923. eCollection 2021.

Editorial: Nephrotic Syndrome in Children

Sami A Sanjad  1 , Tim Ulinski  2 , Bilal Aoun  1
Affiliations
Editorial

Editorial: Nephrotic Syndrome in Children

Sami A Sanjad et al. Front Pediatr. .
No abstract available

Keywords: NPHS1; NPHS2; corticosteroids; immunosuppressives; interleukins; mycophenolate mofetil; nephrotic syndrome; rituximab.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Nephrotic Syndrome in Children

References

    1. Andolino TP, Reid-Adam J. Nephrotic syndrome. Pediatrics. (2015) 36:117–26.e9. 10.1542/pir.36-3-117 - DOI - PubMed
    1. Kemper MJ, Valentin L, van Husen M. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options. Pediatr Nephrol. (2018) 33:1641–9. 10.1007/s00467-017-3780-7 - DOI - PubMed
    1. Hahn D, Hodson EM, Willis NS, Craig JC. Corticoid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. (2015) 2015:CD001533. 10.1002/14651858.CD001533.pub5 - DOI - PMC - PubMed
    1. Iijima K, Sako M, Kamei K, Nozu K. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials. Pediatr Nephrol. (2018) 33:1449–55. 10.1007/s00467-017-3746-9 - DOI - PMC - PubMed
    1. Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, et al. . Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int. (2013) 84:1025–33. 10.1038/ki.2013.211 - DOI - PMC - PubMed

Publication types

LinkOut - more resources